Celularity resolves Nasdaq listing compliance issue

Celularity (CELU) announced that the Nasdaq Listing Qualifications Hearings Panel has cancelled the hearing regarding Celularity’s non-compliance with Nasdaq Listing Rules as the company has cured its filing delinquency. The matter is now closed, and Nasdaq has confirmed that Celularity’s stock will continue to be listed and traded on The Nasdaq Stock Market. Celularity filed its Form 10-Q for the period ended March 31 on October 16, and its Form 10-Q for the period ended June 30, on November 7, achieving compliance with Nasdaq requirements.